The IPO Window Narrows — and It Isn't the Market That Closed It

US listings have slowed to a trickle. EG Group, Holtec, Oura and SB Energy have paused their plans, Anthropic's debut has slipped to mid-November and OpenAI's to next year, the Financial Times reports. Yet the S&P 500 sits near a record and volatility is low, the conditions bankers normally wait for. What changed is the aftermarket. This year's listings have rewarded the people who got shares at the offer and the private holders who sold, not the investors who bought on day one, and buyers have noticed.

The Setup

According to the Financial Times (October 4, 2026), a run of US listings has been put on hold in recent weeks. Petrol forecourt group EG Group had hoped to raise about $1 billion at a $9 billion valuation this autumn and has pushed into 2027, while drawing early takeover interest from bidders including Stonepeak. Nuclear group Holtec, smart-ring maker Oura and SoftBank-backed data-centre developer SB Energy have also paused; Bamboo Insurance postponed last month. SB Energy, the FT reports, was targeting a valuation of about $50 billion without a single facility online.

The two deals everyone was waiting for have moved too. Anthropic, whose backers hope for a valuation above $2 trillion, is now expected to list in mid-November, after the US midterm elections and later than previously expected. OpenAI has pushed its IPO into next year. Outside the US, AS Watson has moved its planned $30 billion London–Hong Kong dual listing into next year while it awaits clearance from China's cyber-security regulator, and in the UK Waterstones and Loveholidays have delayed. "All the names we had for 2026 are being pushed back into 2027," one banker told the FT.

This follows a record first half. SpaceX's June IPO raised $86 billion, the largest ever (our debut analysis).

The Concept

An IPO window is set by the aftermarket, not the index. Bankers like to launch deals when stocks are high and volatility is low. But the investors who fill an order book decide mainly on one question: have recent IPOs made money for the people who bought them? When recent deals trade down, new books get thinner and issuers either cut the price or wait.

Where you measure from changes the answer. A new listing's return can be measured from the offer price (what allocated investors paid) or from the first-day price (what anyone buying in the open market paid). A large first-day pop followed by a slow decline can leave the first group flat and the second deeply underwater. Both can be true of the same stock.

The Read

The usual conditions are in place, and deals are still stalling. The S&P 500 is close to its record high and the VIX, the market's gauge of expected volatility, closed at about 15.3 on October 2. On a normal reading of those conditions, the window is open. The FT's sources point to the aftermarket instead.

The two measures tell one story. BCA Research, cited by the FT, finds this year's tech listings have fallen about 23% on average from their first day of trading. QuantLogix's own IPO scoreboard measures from the offer instead: as of October 4, the median recent IPO is 1.6% below its offer price, and only 48% of the last 23 IPOs trade above their offer. Allocated investors have roughly broken even. Investors who bought on the first day have absorbed most of the decline. That matches what one UK investor told the FT: shares "trade higher for a day then bleed out," with books "massively oversubscribed by fast money playing these first-day pops." A former capital-markets banker put the consequence bluntly: "all the gains are for the private holders."

The pipeline is backing up, not emptying. The same scoreboard shows 60 companies with registrations on file but no terms set, only 3 deals with a price range filed (raising about $89 million combined), and 30 listings postponed or withdrawn in the last 120 days. Supply is waiting rather than disappearing, which matters for when it comes back.

Anthropic is absorbing the attention. "Right now no one cares about anything that isn't Anthropic," the head of equity capital markets at a large US asset manager told the FT. A single deal of that size takes a large share of institutional allocation budgets, and few issuers want to price in the weeks before it. Moving Anthropic to mid-November pushes everyone queued behind it later too. The gap between what its backers hope for and where its private rounds have priced is its own question (what $965B, $1.1T and $2T each mean).

The pushback is broader than AI. Valuation scepticism is sharpest for companies tied to the AI build-out, which one banker called "tone deaf". But the delays reach petrol forecourts, hotels and bookshops. The FT also cites volatile oil prices, the war in Iran and a global sell-off in government bonds, though it notes that companies blaming market turbulence may not all have a strong case with the index where it is.

The Action

If you hold pre-IPO or secondary positions, plan for a longer hold. A delay of a quarter or more pushes out the liquidity event, and a last private-round mark is not a guide to the price a cautious public book will pay. Watch for a dual track: EG Group's takeover interest is a reminder that a sale can replace a listing, often at a different price.

If you buy new issues, separate the offer from the first trade. This year's record says the first-day pop has mostly belonged to allocated investors. Buying in the opening print has meant paying the pop and then riding the decline. Also note the supply calendar: on our IPO page the estimated lock-up expiries for Cerebras (CBRS) fall around November 10, SpaceX (SPCX) around December 9 and Bending Spoons (BSP) around December 28. Those dates are estimates until each company confirms them, and they are when early holders become free to sell.

If you are a founder or CFO planning a 2027 listing, the lesson buyers are drawing is about pricing, not timing. A deal priced to trade up and hold is what reopens a window for everyone behind it. A deal priced for the maximum first-day number, then given back, is what closed this one.

What to Watch Next

Anthropic's pricing and first month. Where it prices against its hoped-for valuation, and whether it holds above the offer for weeks rather than a day, will set the tone for the queue behind it.
The share of recent IPOs above their offer. At 48% it is a coin flip. A move back above half would be the clearest sign that books will fill again.
Postponements versus withdrawals. Postponed deals can come back quickly; formal withdrawals of registration statements mean a longer wait.
Lock-up expiries in November and December. Selling by early holders in recent large deals adds supply just as new issuers try to return.
EG Group's choice between a sale and a listing, and AS Watson's regulatory clearance in China.

The Counter

The strongest case against reading this as a turn: much of the pause may simply be timing. Issuers do not want to price in the shadow of the largest AI listing yet, or into the US midterms, and both pass in November. The index is near a record, volatility is low, and 60 companies are still on file. If Anthropic prices well and trades well, the queue could clear quickly. On that view this is congestion, not a closed window.

The numbers also leave room. A 23% average decline from day one can be pulled down by a few large losers, while our median IPO is only 1.6% below its offer. Offer-price investors, the ones whose orders decide whether a book fills, have not been badly hurt. The pushback may be narrower than the headlines suggest: aimed at AI-linked valuations like SB Energy's, rather than at new issues in general.

Key Terms

IPO window: a period when investor demand is strong enough for companies to list on acceptable terms; it opens and closes with how recent IPOs have performed.
Offer price: the price at which shares are sold to investors in the IPO itself, before trading begins.
First-day pop: the gain from the offer price to the first day's trading price.
Lock-up expiry: the end of the period, often about 180 days, during which pre-IPO holders agreed not to sell; it can add supply to the market.
Dual-track process: preparing an IPO and a sale of the company at the same time, then choosing whichever offers better terms.
Postponed vs withdrawn: a postponed IPO keeps its registration on file and can relaunch; a withdrawn one formally pulls its registration statement.

Primary Sources

Financial Times — Wall Street's IPO fervour cools on tepid demand and valuation worries (George Steer, Ashley Armstrong and Ivan Levingston, October 4, 2026; includes the BCA Research figure and all quoted sources)
Financial Times — Altman says OpenAI will delay its IPO until it overcomes safety concerns
QuantLogix IPO Market Scoreboard (share above offer, median move since offer, pipeline by stage, postponements and estimated lock-up dates; live, figures as of October 4, 2026)

QuantLogix is not a registered investment advisor, broker-dealer, or financial planner. This article is for informational and educational purposes only and does not constitute financial advice, investment recommendations, or solicitations to buy or sell securities. Reported IPO plans and timings are those described by the Financial Times and its sources and can change; QuantLogix scoreboard figures are live and were read on October 4, 2026; lock-up dates are estimates until confirmed by the issuer. Past performance does not guarantee future results.